Orchestra BioMed Holdings, Inc. (OBIO) Operating income 2021–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$51.8MFY2025 · since FY2021: -$394,756 → -$51.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.8M | +19.4% |
| FY2024 | -$64.3M | -24.8% |
| FY2023 | -$51.5M | -57.7% |
| FY2022 | -$32.7M | -8172.7% |
| FY2021 | -$394,756 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net incomeOBIO Net marginOBIO Gross profitOBIO Gross marginOBIO Operating marginOBIO Operating cash flowOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →